James Trager - Aug 2, 2021 Form 4 Insider Report for Nkarta, Inc. (NKTX)

Role: Chief Scientific Officer
Signature: /s/ Alicia Hager, as Attorney-in-Fact
Stock symbol: NKTX
Transactions as of: Aug 2, 2021
Transactions value $: -$104,756
Form type: 4
Date filed: 8/4/2021, 04:50 PM
Next filing: Jan 19, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NKTX	Common Stock	Options Exercise	$8.75K	+2.25K	+4.92%	$3.89	48K	Aug 2, 2021	Direct	F1
transaction	NKTX	Common Stock	Sale	-$114K	-3.6K	-7.5%	$31.53^*	44.4K	Aug 2, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NKTX	Stock Option (right to buy)	Options Exercise	$0	-2.25K	-3.9%	$0.00	55.4K	Aug 2, 2021	Common Stock	2.25K	$3.89	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
F2	This option originally covered 62,162 shares of NKTX common stock and was scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 1, 2020.